Mode
Text Size
Log in / Sign up

Low circulating omega-3 fatty acids linked to altered myocardial strain in hypertensive patients with preserved ejection fractionYour Fish Oil Level May Reveal Hidden Heart Strain

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that specific omega-3 fatty acids associate with strain parameters in hypertensive patients with preserved ejection fraction.

This retrospective cohort study analyzed data from 364 patients with preserved left ventricular ejection fraction, comprising 179 individuals with hypertension and 185 controls. The primary exposure was circulating omega-3 polyunsaturated fatty acid (PUFA) levels, assessed against left cardiac myocardial strain as the primary outcome. Secondary outcomes included left atrial functional parameters and left ventricular strain parameters.

The analysis revealed no significant differences in total omega-3 PUFA levels or their subtypes between the hypertensive and control groups, with all p-values greater than 0.05. However, specific fatty acids—docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA)—were independently and negatively associated with multiple left ventricular strain parameters. Similarly, these specific fatty acids demonstrated independent negative associations with left atrial functional parameters.

No adverse events, serious adverse events, discontinuations, or tolerability issues were reported in this observational analysis. The study design inherently limits causal inference, as the title and abstract explicitly describe associations rather than causation. Regression methods were used to examine these relationships without establishing a cause-and-effect link.

Clinicians should interpret these results as observational associations only. The findings may inform future research into omega-3 status in hypertensive populations but do not currently support changing clinical management based on these specific fatty acid levels alone. Further prospective studies are needed to clarify the role of these nutrients in cardiac function.

A quiet problem hiding in plain sight

Imagine a friend in her 50s. Her blood pressure is a little high, but her heart scan looks "normal." She feels fine. Yet deep inside her heart muscle, tiny changes may already be happening.

A new study suggests doctors might spot those hidden changes using something surprising — the level of omega-3 fats in her blood.

High blood pressure, also called hypertension, affects nearly half of all adults in the United States. Over time, it forces the heart to work harder with every beat.

At first, the damage is invisible. Standard tests like ejection fraction (a measure of how much blood the heart pumps out) often look fine, even when the muscle itself is quietly stiffening.

That's the frustrating part. By the time most tests turn abnormal, the heart has already lost ground. Doctors have long wanted an earlier warning sign — something simple, like a blood test.

The old view, and a new twist

For years, doctors mostly focused on blood pressure numbers and cholesterol. Omega-3 fatty acids — the "good fats" in fish like salmon and sardines — were mainly studied for lowering triglycerides and protecting against heart attacks.

But here's the twist. This new study didn't look at heart attacks. It looked at something much subtler: how well the tiny muscle fibers of the heart stretch and squeeze with each beat.

And it found that people with higher omega-3 levels tended to show different patterns of heart "strain" than people with lower levels.

How it works, in plain language

Think of your heart like a balloon. With each beat, it fills, stretches, twists, and snaps back. When the muscle is healthy, it stretches smoothly.

When blood pressure stays high, the balloon walls get thicker and stiffer. The twisting motion loses a bit of its snap. That loss of motion is called reduced "strain."

Omega-3 fats seem to act like oil for that balloon. They may help keep cell walls flexible and calm down inflammation — the kind of slow, low-grade irritation that stiffens tissue over time.

The study measured three key omega-3s:

  • EPA (eicosapentaenoic acid)
  • DHA (docosahexaenoic acid)
  • DPA (docosapentaenoic acid)

All three are found in fatty fish and fish oil.

Researchers at Frontiers in Medicine looked back at 364 adults who had detailed heart MRI scans. About half had high blood pressure, and half did not. Everyone in the study still had normal pumping function on standard tests.

The team used a special MRI technique called feature tracking to measure tiny motions of the heart muscle — something regular scans can miss.

In people with high blood pressure, higher levels of EPA, DHA, and DPA were linked to measurable differences in how the heart muscle moved. The links showed up in both the main pumping chamber (the left ventricle) and the upper filling chamber (the left atrium).

In plain English: omega-3 levels tracked along with subtle heart muscle changes that you can't feel and that basic tests don't catch.

Interestingly, overall omega-3 levels were not very different between people with and without hypertension once age, weight, and other factors were taken into account. The connection showed up only when researchers looked deeper — at the motion of the muscle itself.

This doesn't mean taking fish oil will reverse heart strain.

Where things get interesting

Here's the catch. The study doesn't prove omega-3s cause better or worse heart motion. It only shows the two are linked.

It's possible that people with healthier diets, more exercise, or better overall health simply have both higher omega-3 levels and smoother heart motion. The fats may be a marker of good health, not the cause of it.

The bigger picture

This research fits into a growing trend in cardiology: looking for early, hidden signs of heart stress before the heart starts to fail. Tools like cardiac MRI and blood biomarkers are helping doctors zoom in earlier than ever.

If future studies confirm the pattern, a simple omega-3 blood level could become one small piece of a bigger puzzle — not a diagnosis by itself, but a clue.

If you have high blood pressure, the best-supported steps remain the basic ones: take your blood pressure medicine, stay active, limit salt, and eat a heart-healthy diet that includes fish a couple of times a week.

Do not start high-dose fish oil supplements based on this study alone. Talk to your doctor first, especially if you take blood thinners or have other health conditions.

This blood test is not something you can ask for today to check your heart strain. It's still a research tool.

Honest limitations

The study was small and looked back in time, which makes it harder to prove cause and effect. It was done at a single center, and most patients had similar backgrounds. The findings need to be repeated in larger, more diverse groups before doctors can act on them.

The next step is larger studies that follow people over years — tracking their omega-3 levels, their heart scans, and what actually happens to their health. Researchers also want to test whether raising omega-3 levels through diet or supplements can protect the heart muscle in people with high blood pressure. That kind of trial takes time, often five years or more, because heart changes happen slowly. For now, this study opens an interesting door — and gives scientists a clearer sense of where to look next.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveTo assess the association between circulating polyunsaturated fatty acids (PUFAs) and left cardiac myocardial strain in hypertensive patients using cardiac magnetic resonance feature tracking.MethodsThis retrospective study included 364 patients with preserved left ventricular ejection fraction (179 hypertensive, 185 controls). Left atrial (LA) and left ventricular (LV) strain parameters were derived from CMR images using CVI42 software. Group comparisons were performed using independent t-tests, ANCOVA, Mann–Whitney U tests, or chi-square tests as appropriate. Univariate and multivariable linear regression were used to examine associations between ω-3 PUFA levels and myocardial strain parameters. Logistic regression and ROC curve analysis were conducted to evaluate predictive value. Inter-observer agreement was assessed using intraclass correlation coefficients.ResultsAfter adjustment for age, sex, BMI, blood pressure, triglycerides, and creatinine, no significant differences in ω-3 PUFA levels or their subtypes were observed between groups (all p > 0.05). In hypertensive patients, docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) were independently and negatively associated with multiple LV strain parameters, including mid-wall longitudinal strain, global radial strain, mid-wall radial strain, mid-wall circumferential strain, and apical longitudinal strain, as well as LA functional parameters, including reservoir strain and strain rate (all p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.